We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
@Joker99
You describe Porkys forecast as nonsense without explanation !
What each individual would do in the meantime is a different issue.
Don't like forecasts or high expectations myself but please have the decency to explain your initial remark.
A little reminder at £8 we were pricing in DCSH 100 million extension which then imploded. The ‘blue sky valuation’ of £36 was if we had won phase 2 with the government which doesn’t look needed now. So those are off the table. The positives are that there are lots of other revenue streams ( some of them could be rather juicy) that were not even on the radar at that point. Airport testing, variplex might see bigger sales this winter if flu makes a return, expansion into another country, mergers. Yes, it’s all jam tomorrow but that’s the challenge to the company, get us some jam today and we might be able to start seeing the higher valuations sooner rather than later. For now I’d be happy with a slow uptick to £6 whilst we sort out the dispute and then let us start seeing the jam today please Graham!!
@milnrowmug
I would like to assist you on your valuation questions;
You might be aware that I come from a VERY Bullish position on this. Some here class me as the "resident ramper" I don't much care, you see I have spent hours and hours researching this business, its history in the making as far as i'm concerned.
It's a fantastic business that will reach fair mid cap status (3bn - 6bn) from my perspective. This is why I'm so passionate about it. They have one of the best R&D teams in this sector in the world, they are working solidly on delivering sales supplying to 150 countries, they are shockingly crap at Share Holder communication but ultimately the figures will speak for themselves once the share is properly rated. I hold a £ 54 SP target. I accept this looks ridiculous at the moment with the share price at this level, but i consider the current share price to be less than the "fire sale" value of the company.
My target is based on an EV/EBITDA Valuation VERY similar to the calculation prepared here by Blackbird Investing. He details the calculation perfectly:-
https://www.powerof78.com/2021/04/11/ncyt-blackbird-investing/
A lot here depends on your perspective of the Covid Outlook. I believe that we will have to learn to live with it and variants will keep coming. just like the flu virus we will need to be on our guard and keep updating. Diagnostics worldwide is becoming a VERY important sector as a result. As such i consider revenues will remain high for at least the next four years and within that time Novacyt will further establish itself within other diagnostics related verticals.
The business is doing some great work in Cancer Tumor Testing, New tests in maternity to replace the current invasive tests used during pregnancy at the moment. They are involved in veterinary diagnostics and numerous other diagnostics areas that we rarely discuss due to the heavy focus on Covid but they are diversifying further.
Of course the Covid pandemic worldwide is attracting the most attention, Novacyt are busy supporting the world in this direction. They have the only tests picking up ALL variants. As i say its a fantastic business.
Blackbird Investing considers £ 49.69 (£3.5bn mcap) as his BULLISH top end price for this stock and £ 13.80 as his most bearish position. This was before todays RNS of further product reach.
I have mashed these figures around in numerous ways. Comparing Novacyt to other Diagnostics businesses on other exchanges and i still come back to my bullish rating of £54.
You see what throws the current valuation out at the moment is that the market still does not know how to value Novacyt. Originally it was considered as a one hit wonder and that Covid would blow over quickly hence it was on a cash rating and remains on that. This is about to change as this is no longer the case. The recent framework award for example was on a 4 year deal, reconfirming the LONGEVITY argument. So in my mind a re-valu
OK, thanks for view, imo expect further work and product.
Indeed Hydr. Take care
Airlineboy - much respect to that poster. Nerves of steel.
Milnrow- yes we know that the company was estimating coronavirus sales to drop off In the second half of this year.
When the company release a statement to say otherwise I’ll be pleasantly surprised but all the broker forecasts plan for this. For me the valuation of Ncyt is about what sort of company will be left behind after Covid.
40 million profit a year /70 million shares x pe of 10-20
Is a share price of £6-11
That’s my bottom valuation..... if they start doing the right things and building out future revenues beyond Covid then that valuation can fly higher...
Hydr - I suspect that certain poster will have the last laugh. VERY good luck to her! I think most if not all of us will do very well, even if bought in near the top. Just my personal belief. The usual caveat applies DYOR
Mburns-thankyou. it is much easier said than done. I wish I had followed that strategy and got out at £10 after the double top but I got caught up in it all.
I don’t mind holding good companies for long providing I can afford to double down. But with Ncyt that was impossible as it had grown so big. There was a holder who posted her portfolio on Twitter ( won’t name names ) but I was surprised as their holding in Ncyt was huge (100kplus)....not the kind of cash that most can double down on. I would not have been holding that kind of cash through a drop like that. (I’d be paying of my mortgage) Stop loss would have been on and it would have been well and firmly triggered. But each to their own.
Hydr, do we know sales are dropping off?
Mac.... rephrase.... keep delivering. Salesman’s mantra.... you are only as good as your last sale.
We know sales are dropping off, if we don’t want sales price to rerate down as it does, then we need to start replacing the Covid revenue with stable and growing revenue streams. It’s all to play for and from today’s RNS it’s sounds like we are capitalising on coronavirus. I’d like to see some progress into other growth avenues though. Oncology for example.
Start delivering? We ourselves set the expectations too high. They delivered nearly €300m sales last year. Is that not delivering?
Hydr - you've made a very sensible decision so far, wish I had sold my half as early as you but it's difficult when it's in free fall to make a quick decision, you know the fundamentals but the reality is the fundamentals aren't being supported. Thankfully Mullis did a complete turn around and got an excellent RNS out. I agree this is still an uphill task and I'll be treating it slowly but surely...........
@KilkennyTed
Fortune favours the brave.
Maybe he's having a night out on the tiles with that not so cool cat that used to hang around here for a while.
I love dusseldorf, cracking city
Did I miss the new blog today apologies if so
https://blog.primerdesign.co.uk/global-bioinformatics-surveillance-drives-innovation-in-sars-cov-2-variant-detection-tests/
No I’m not saintsmith.
The stock had been in a stage 4 drop up until today and the company had only released very bearish news. I said I would buy back in when sentiment shifted and I jumped back in at 8 on the bell. I had a strategy and I executed, protected my capital by selling out and got back in 50p lower. Happy days. If Graham had drip fed some of this news a week ago perhaps it would have stopped the rot sooner but you can’t blame me for wanting to protect capital. My holding was too large for me to double down so it was either take the loss on the chin or sell out and try get back in lower if the company showed me some confidence, which they have.
To be absolutely honest I think we have a big challenge ahead of us. £6-8 is now on the cards but I could see it selling off with no news. if we want £15plus then the company need to start delivering and communicating on the non DCSH growth. Contracts, airports, mergers and acquisitions
Düsseldorf I believe :))))
Where's Fartuner today?
Pull the other one Troublesome
@Saintsmith
Lol - Wonder if the 2 bells can summon up ' O Come All Ye Faithful '.
Saintsmith I have hydr blocked for obvious reasons and now I nearly fell off my chair another turn cost pops up funny that.
Anyway love that bullseye graphic.
Moretti non alcoholic tonight pushing the boat out all mine yeeeha
Hydr31 , your another one singing from a different hymn sheet now . Joker also , I’ve got your cards marked you pair of bell pieces ;)
LOL
I was looking at fit to fly this yesterday....Did someone have evidence this is our PCR? Also noticed they are offering an LFT as some destinations require it. I wonder? A nice big contract with the airlines could certainly turn the tide and get £15 back on the table. Great move getting an LFT approved. All based covered.
Cheers Kaeren, you too and all true believers!